Pimonpan Jinda

Pimonpan Jinda

Auto-generated profile, based on publicly available information

Pimonpan Jinda

Mahidol University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2023 in Expert Opinion on Drug Metabolism & Toxicology
Verified
Journal Article
Closed access
Mohitosh BiswasMohitosh Biswas
Mohitosh Biswas
PJPimonpan Jinda
Pimonpan Jinda
CSCHONLAPHAT Sukasem
CHONLAPHAT Sukasem
Various pharmacogenomic (PGx) variants differ widely in different ethnicities. and clinical outcomes associated with these variants may also be substantially varied. Literature was searched in diff...

4 March 2023 in Expert Opinion on Drug Metabolism & Toxicology
Verified
Journal Article
Closed access
Mohitosh BiswasMohitosh Biswas
Mohitosh Biswas
JSJohn Shobana
John Shobana
PJPimonpan Jinda
Pimonpan Jinda
CSCHONLAPHAT Sukasem
CHONLAPHAT Sukasem
Azole antifungal drugs are commonly prescribed to treat invasive fungal infections in various disease conditions. However, these drugs are substrates and inhibitors of cytochrome P450 (CYP) enzymes...

19 September 2025 in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
Verified
Journal Article
Closed access
PJPimonpan Jinda
Pimonpan Jinda
PKPimpun Kitpoka
Pimpun Kitpoka
WTWimol Thienphopirak
Wimol Thienphopirak
SCSuwat Chiawchan
Suwat Chiawchan
SPSantirhat Prommas
Santirhat Prommas
APApichaya Puangpetch
Apichaya Puangpetch
Background: Thiopurine S-methyltransferase (TPMT) is crucial for metabolizing thiopurine drugs. This study aimed to establish the cutoff values for TPMT activity in a cohort of healthy individuals. We defined normal TPMT activity ranges and identified clinically applicable thresholds to distinguish individuals with normal TPMT function from those with reduced or deficient activity. Methods: A total of 457 participants, including 207 children and 250 healthy adults without prior thiopurine drug exposure, were enrolled. TPMT activity was measured and common defective genetic variants ( TPMT*3A, TPMT*3B, and TPMT*3C ) were detected. To determine TPMT activity cutoff values and maximize sensitivity and specificity, receiver operating characteristic curve analysis was employed. Results: The cutoff values for TPMT activity in children were ≥52.9 nmol 6-MMP/g Hb/h for persons of the wild type and <52.9 nmol 6-MMP/g Hb/h for individuals who were heterozygous. In adults, the cutoff values were ≥44.6, 31.58–44.5, and <31.58 nmol 6-MMP/g Hb/h for wild-type, heterozygous, and compound heterozygous individuals, respectively. The sensitivity and specificity were 79.29% and 100% in children, whereas, in adults, they were 61.86% and 78.57%, 38.46% and 64.73%, and 100% and 95.98% in the wild-type, heterozygous, and compound heterozygous, respectively. Conclusions: Identifying TPMT activity cutoff values is crucial for managing patients receiving thiopurine therapy, especially in Thailand. This approach allows for personalized treatment plans and minimizes the risk of adverse drug reactions. Since TPMT activity cutoff values can differ by population and testing methods, it is important to establish specific cutoff values locally.